AI Predicts High-Dose Ivermectin and Mebendazole Combined with Supplements and Diet/Lifestyle Improved Survival in Stage 4 Prostate Cancer
Abstract Background : Stage 4 prostate cancer remains largely incurable, and new strategies are urgently needed. Preclinical evidence suggests antiparasitic agents such as ivermectin and mebendazole, when combined with anti-inflammatory supplements and lifestyle changes, may offer survival benefits. Objective : To simulate the long-term efficacy and safety of a combined therapeutic protocol including high-dose ivermectin, mebendazole, nutritional supplements, and structured lifestyle changes in patients with stage 4 prostate cancer. Methods : A double-blind, randomized, placebo-controlled simulation trial was designed with 10,000 patients per arm over a 10-year follow-up. The intervention arm received high-dose ivermectin (1 mg/kg, 5x/week), mebendazole (500 mg BID), supplements (vitamin D, curcumin, omega-3, EGCG, berberine), and a structured diet/lifestyle protocol. The control arm received standard of care plus placebo. Survival outcomes and adverse event rates were simulated usi...